ATAD1 and malaria: The ‘Combination B’ malaria vaccine, one of the few to reach field trials, demonstrated strain-specific anti-parasite effects despite being comprised of an allele of each of 3 asexual blood stage proteins, MSP-1, MSP-2 and RESA (ring-infected erythrocyte surface antigen) [29].